How do you stay in the know and sharpen your competitive edge? One surefire route: Attending GRx+Biosims November 4-6 in North Bethesda, MD. This unique event brings industry leaders together with regulatory and other government stakeholders.
Discover the GRx+Biosims agenda here. Former FDA Commissioner Dr. Scott Gottlieb, Modern Healthcare’s number one Most Influential Clinical Executive of 2019, is just one of the luminaries scheduled to appear. Of course, networking and informal conversations matter just as much as the official remarks and sessions.
Recap: Highlights From GRx+Biosims 2018
Whether you come from the technical, policy, regulatory or legal side of our multifaceted industry, GRx+Biosims offers ample opportunity to advance your career and organizational objectives.
Other confirmed speakers:
- Patrizia Cavazzoni, M.D.
Deputy Director for Operations, CDER, FDA
- Sally Choe, PhD
Director, Office of Generic Drugs (OGD), CDER, FDA
- Alonza Cruse
Director, Office of Pharmaceutical Quality Operations Office of Regulatory Affairs (ORA), CDER, FDA
- Michael Kopcha, PhD, RPh
Director, Office of Pharmaceutical Quality (OPQ), CDER, FDA
- Ronald Piervincenzi
Chief Executive Officer, United States Pharmacopeial Convention
- Sarah Yim, M.D.
Acting Director for Therapeutic Biologics, Office of New Drugs, Therapeutic Biologics and Biosimilars Team, CDER, FDA
Are you interested in attending but need help persuading a decision-maker to give you the green light? Download our customizable Justification Toolkit here.
What do you think would make a great GRx+Biosims session topic? Share your ideas here!
If you have a product or service of interest to generics and biosimilars industry professionals, the exposition at GRx+Biosims 2019 is a can’t-miss chance to showcase your company. Find out more.
Do you want to find out more about sponsoring GRx+Biosims 2019? Contact me at Jennifer.Soup@accessiblemeds.org.
By Jennifer Soup, AAM Director, Meetings & Marketing